Tanshinol alleviates ulcerative colitis by promoting the expression of VLDLR.

Zhu, Huanhuan; Tong, Shaopeng; Cui, Yan; Wang, Xiaodong; Wang, Minying

Zhu, Huanhuan; Tong, Shaopeng; Cui, Yan; Wang, Xiaodong; Wang, Minying.

Afiliação

Zhu H; Department of Anorectal Surgery, Wuxi Traditional Chinese Medicine Hospital, Wuxi, PR China.
Tong S; Endoscopic Center, Wuxi YEBO Proctology Hospital of Traditional Chinese Medicine, Wuxi, PR China.
Cui Y; Department of Infection Control, Wuxi Traditional Chinese Medicine Hospital, Wuxi, PR China.
Wang X; Department of Traditional Chinese Medicine, Wuxi YEBO Proctology Hospital of Traditional Chinese Medicine, Wuxi, PR China.
Wang M; Department of Anorectal Surgery, Wuxi Traditional Chinese Medicine Hospital, Wuxi, PR China.

Drug Dev Res ; 82(8): 1258-1268, 2021 12.

Article em En | MEDLINE | ID: mdl-34145621

Assuntos

Ácidos Cafeicos/uso terapêutico; Colite Ulcerativa/tratamento farmacológico; Receptores de LDL/fisiologia; Animais; Apoptose/efeitos dos fármacos; Ácidos Cafeicos/farmacologia; Sobrevivência Celular/efeitos dos fármacos; Células Cultivadas; Colite Ulcerativa/metabolismo; Masculino; Camundongos; Camundongos Endogâmicos C57BL; Receptores de LDL/análise; Receptores de LDL/genética

Palavras-chave

apoptosis; inflammation response; tanshinol; ulcerative colitis; viability

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Cafeicos / Receptores de LDL / Colite Ulcerativa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google